Building the Next Generation of Biotech Companies and Advancing Muscular Dystrophy Research

In this Mission Matters episode, Adam Torres interviews David Craig, President & CEO of SARCOMATRIX. David shares lessons from helping build leading biotech companies, explains how founders can navigate today's challenging funding environment, and discusses his mission to develop innovative therapies for muscular dystrophy and other muscle-wasting diseases while supporting the next generation of biotech entrepreneurs. 🙏 Big thanks to ⁠⁠⁠Shawn Garrity⁠⁠⁠, Founder of Circle and ⁠⁠⁠SEICon⁠⁠⁠ and ⁠⁠⁠Brad Turner⁠⁠⁠, Founder & CEO at Marketing Completion Fund & ⁠⁠⁠Investor Conference News⁠⁠⁠ for inviting Las Vegas Live to SEICon! Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices